Search
for

    Products matching "androgenic compounds"

    Tracking 3 products like 278 Mane Regain - RU58841 5% Solution, 260 RU58841 Powder and 260 RU58841 Powder from by companies like Amazon and Anageninc. View all 3 products »

    Learn

    5 / 47 results

      learn GT20029

      research compound made to degrade androgen receptors in scalp

      learn Finasteride

      Frontline, gold standard treatment for combatting androgenic alopecia

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Sulforaphane

      compound from cruciferous vegetables has some mild effects on DHT

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Which compounds in Saw Palmetto are actually beneficial?

      in Research/Science  2 upvotes 1 year ago
      Saw palmetto's fatty acids, particularly lauric and linoleic acids, inhibit enzymes linked to hair loss, while sterols like beta-sitosterol are less effective due to poor absorption. The conversation questions which specific compounds in saw palmetto contribute to its anti-androgenic effects.

      community Chat is this real? Compound called clascoterone

      in Research/Science  583 upvotes 3 months ago
      Clascoterone shows promising results for hair regrowth in men with androgenetic alopecia, with potential FDA approval by 2026. It acts as a topical androgen receptor blocker, offering a new treatment option with minimal side effects compared to existing treatments like finasteride.

      community Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World’s First Topical Use PROTAC Compound

      in Research/Science  126 upvotes 3 years ago
      The conversation discusses positive initial trial results for GT20029, a topical compound for hair loss that degrades androgen receptors, potentially requiring only weekly application. Participants express hope for this treatment to be more effective and convenient than current options like Minoxidil, Finasteride, and RU58841.

      community The story of RU58841/PSK3841

      in Research/Science 1 year ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.

      community GT20029. Kintor Pharma’s Product

      in Research/Science  12 upvotes 3 years ago
      The conversation discusses GT20029, a compound by Kintor Pharma that degrades androgen receptors and is in trials, with potential as a hair loss cure. Another promising treatment mentioned is an antibody that blocks prolactin and has shown positive results in macaques.